Protein Expression and Purification of Romiplostim and Analysis of Its Secretory Production Using an In Silico Investigated Signal Peptide in E. Coli

سال انتشار: 1402
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 68

فایل این مقاله در 9 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_RBMB-12-1_003

تاریخ نمایه سازی: 31 مرداد 1402

چکیده مقاله:

Background: Romiplostim is a thrombopoietin receptor agonist approved for the treatment of immune thrombocytopenia. It is produced by recombinant DNA technology in Escherichia coli. Many researchers have studied the periplasmic or extracellular production of recombinant proteins in E. coli by using signal peptide sequences due to its advantages compared to intracellular production. In this study, the effect of the pelB signal peptide on Romiplostim production was analyzed. Methods: The nucleotide sequence of Romiplostim was codon optimized for expression in E. coli BL۲۱. For analysis of the effect of the pelB signal peptide, pET-۲۲b (+) and pET-۱۵b plasmids were used. The probability of signal peptide cleavage and pathway was predicted by using the SignalP ۵.۰ program, and expression, purification, and biological activity of the recombinant protein were analyzed. Results: In-silico analysis predicted the correct cleavage of the pelB signal peptide. However, the experimental results showed intracellular accumulation of the protein in fusion with this signal peptide without any detectable protein band in periplasmic or extracellular spaces. The in-vivo experiment of purified protein without signal peptide exhibited a significant increment in platelets compared to the control group. Conclusions: Romiplostim was expressed in E. coli with and without signal peptide. The latest one showed suitable in-vivo bioactivity. Despite the results of in-silico prediction, the pelB signal peptide could not transport the protein into the periplasm or extracellular environment in the experimental condition. Trying different signal peptides and more in-silico analysis might be helpful for the efficient secretion of the Romiplostim protein.

نویسندگان

Masoud Hashemzaei

Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran & Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.

Manica Negahdaripour

Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran & Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.

Reza Heidari

Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Mohammad Bagher Ghoshoon*

Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Ira & Biotechnology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Cines DB, Yasothan U, Kirkpatrick P. Romiplostim. Nat Rev Drug ...
  • Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J ...
  • Psaila B, Bussel JB. Immune thrombocytopenic purpura. Hematol Oncol Clin ...
  • Stasi R, Provan D. Management of immune thrombocytopenic purpura in ...
  • McMillan R. The pathogenesis of chronic immune thrombocytopenic purpura. Semin ...
  • Zainal A, Salama A, Alweis R. Immune thrombocytopenic purpura. J ...
  • Calmettes C, Vigouroux S, Tabrizi R, Milpied N. Romiplostim (AMG۵۳۱, ...
  • Nplate (romiplostim) information [Internet]. U.S. Food and Drug Administration. FDA; ...
  • Janssens A. Romiplostim for the treatment of primary immune thrombocytopenia. ...
  • Choi J, Lee S. Secretory and extracellular production of recombinant ...
  • Ghoshoon MB, Berenjian A, Hemmati S, Dabbagh F, Karimi Z, ...
  • Kleiner‐Grote GR, Risse JM, Friehs K. Secretion of recombinant proteins ...
  • Yoon SH, Kim SK, Kim JF. Secretory production of recombinant ...
  • Pechsrichuang P, Songsiriritthigul C, Haltrich D, Roytrakul S, Namvijtr P, ...
  • Mirzadeh K, Shilling PJ, Elfageih R, Cumming AJ, Cui HL, ...
  • Owji H, Nezafat N, Negahdaripour M, Hajiebrahimi A, Ghasemi Y. ...
  • Wang J, Xu S, Pang Y, Wang X, Chen K, ...
  • Zamani M, Nezafat N, Negahdaripour M, Dabbagh F, Ghasemi Y. ...
  • Chuan-Fa Liu, Ulrich Feige, Cheetham JC, inventors. Thrombopoietic compounds. USA ...
  • Froger A, Hall JE. Transformation of plasmid DNA into E. ...
  • Ghasemi Y, Ghoshoon MB, Taheri M, Negahdaripour M, Nouri F. ...
  • Negahdaripour M, Nezafat N, Heidari R, Erfani N, Hajighahramani N, ...
  • Gallagher SR. SDS‐polyacrylamide gel electrophoresis (SDS‐PAGE). Curr Protoc Essent Lab ...
  • Hober S, Nord K, Linhult M. Protein A chromatography for ...
  • Fayaz S, Fard-Esfahani P, Golkar M, Allahyari M, Sadeghi S. ...
  • Bradford MM. A rapid and sensitive method for the quantitation ...
  • Sadraeian M, Rasoul-Amini S, Mansoorkhani MJK, Mohkam M, Ghoshoon MB, ...
  • Arakawa T, Ejima D. Refolding technologies for antibody fragments. Antibodies. ...
  • Kötzler MP, McIntosh LP, Withers SG. Refolding the unfoldable: A ...
  • Li A, Kato Z, Ohnishi H, Hashimoto K, Matsukuma E, ...
  • Karimi Z, Nezafat N, Negahdaripour M, Berenjian A, Hemmati S, ...
  • Chung BH, Sohn M-J, Oh S-W, Park U-S, Poo H, ...
  • Su L, Xu C, Wu J. Extracellular expression of Thermobifida ...
  • Shi L, Liu H, Gao S, Weng Y, Zhu L. ...
  • Negahdaripour M, Nezafat N, Hajighahramani N, Soheil Rahmatabadi S, Hossein ...
  • Freudl R. Signal peptides for recombinant protein secretion in bacterial ...
  • Hashemzaei M, Nezafat N, Ghoshoon MB, Negahdaripour M. In-silico selection ...
  • Mohammadi F, Nezafat N, Berenjian A, Negahdaripour M, Zamani M, ...
  • نمایش کامل مراجع